Compare SITM & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SITM | ELAN |
|---|---|---|
| Founded | 2003 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 10.3B |
| IPO Year | 2019 | 2018 |
| Metric | SITM | ELAN |
|---|---|---|
| Price | $361.66 | $24.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 10 |
| Target Price | ★ $355.00 | $24.44 |
| AVG Volume (30 Days) | 234.6K | ★ 4.7M |
| Earning Date | 02-04-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | $281,486,000.00 | ★ $4,591,000,000.00 |
| Revenue This Year | $58.61 | $7.25 |
| Revenue Next Year | $39.35 | $5.69 |
| P/E Ratio | ★ N/A | $340.63 |
| Revenue Growth | ★ 59.04 | 3.08 |
| 52 Week Low | $105.40 | $8.02 |
| 52 Week High | $393.80 | $25.29 |
| Indicator | SITM | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 53.38 | 63.40 |
| Support Level | $340.78 | $24.27 |
| Resistance Level | $393.80 | $25.29 |
| Average True Range (ATR) | 18.89 | 0.73 |
| MACD | -1.04 | 0.05 |
| Stochastic Oscillator | 51.43 | 81.71 |
SiTime Corp is a provider of silicon timing systems solutions. The company designs develops and sell silicon timing systems solutions for different industries including automotive, infrastructure, aerospace-defense, consumer, internet of things, consumer and industrials. Its product offerings include Stratum 3E DCOCXOs, Programmable OCXOs, MHz Oscillators, 32.768 kHz Oscillators, Embedded Resonators, Precision MHz Super-TCXOs, and Ruggedized Oscillators. It sells its products around Taiwan, Hong Kong, the United States, and other regions and generates the majority of its revenue from Taiwan.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.